Search Results - "Ding, Yanhua"
-
1
Acrylic resins with oxetane pendant groups for free radical and cationic dual-curing photoresists
Published in Materials & design (01-01-2022)“…[Display omitted] •An oxetane pendant groups-containing acrylic resin can achieve cationic photocuring.•The dry film photoresist based on the resin had a…”
Get full text
Journal Article -
2
Effects of ultrasound on the thawing of quick-frozen small yellow croaker (Larimichthys polyactis) based on TMT-labeled quantitative proteomic
Published in Food chemistry (01-01-2022)“…•Dual-frequency ultrasound thawing (DUT) was used to treated small yellow croaker.•The small yellow croaker treated by DUT exhibited satisfactory quality…”
Get full text
Journal Article -
3
Effect of slit dual-frequency ultrasonic emulsification technology on the stability of walnut emulsions
Published in Ultrasonics sonochemistry (01-01-2022)“…•Slit dual-frequency ultrasonic was used to emulsify walnut emulsions.•Oil droplets and protein particles were decreased by ultrasonic emulsification.•The…”
Get full text
Journal Article -
4
Evaluating the efficacy of 8 non-invasive models in predicting MASLD and progression: a prospective study
Published in BMC gastroenterology (14-10-2024)“…Selecting the optimal non-invasive diagnostic model for MASLD (Metabolic Dysfunction-Associated Steatosis Liver Disease) and steatosis progression is a…”
Get full text
Journal Article -
5
Coumarin Ketoxime Ester with Electron-Donating Substituents as Photoinitiators and Photosensitizers for Photopolymerization upon UV-Vis LED Irradiation
Published in Polymers (28-10-2022)“…High-performance photoinitiators (PIs) are essential for ultraviolet–visible (UV-Vis) light emitting diode (LED) photopolymerization. In this study, a series…”
Get full text
Journal Article -
6
A phase 1 randomized study compare the pharmacokinetics, safety and immunogenicity of HLX04 to reference bevacizumab sourced from the United States, the European Union, and China in healthy Chinese male volunteers
Published in Cancer chemotherapy and pharmacology (01-09-2021)“…Purpose To compare the pharmacokinetic profiles, safety and immunogenicity of proposed bevacizumab biosimilar HLX04 with reference bevacizumab in healthy…”
Get full text
Journal Article -
7
Type-I-IFN-Stimulated Gene TRIM5γ Inhibits HBV Replication by Promoting HBx Degradation
Published in Cell reports (Cambridge) (10-12-2019)“…To understand the molecular mechanisms that mediate the anti-hepatitis B virus (HBV) effect of interferon (IFN) therapy, we conduct high-throughput bimolecular…”
Get full text
Journal Article -
8
A randomized trial comparing LY01011, biosimilar candidate, with the reference product denosumab (Xgeva®) in healthy Chinese subjects
Published in Journal of bone oncology (01-10-2023)“…• Patients with bone metastasis from solid tumors could experience skeletal related events, which lead to impaired functional status and quality of life. • The…”
Get full text
Journal Article -
9
Safety, tolerability and pharmacokinetics of forsythin in healthy subjects: a double-blinded, placebo-controlled single-dose and multiple-dose escalation and food effect study
Published in Annals of medicine (Helsinki) (2023)“…Forsythin, an active compound from Forsythiae Fructus, has the potential to treat the common cold and influenza through its antipyretic-analgesic,…”
Get full text
Journal Article -
10
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Ascending Dose and Food Effect Study to Evaluate the Tolerance, Pharmacokinetics of Jaktinib, a New Selective Janus Kinase Inhibitor in Healthy Chinese Volunteers
Published in Frontiers in pharmacology (14-12-2020)“…Jaktinib is a novel selective janus kinase 1/2 inhibitor. The phase I first-in-human study evaluated the tolerance and pharmacokinetics of jaktinib in healthy…”
Get full text
Journal Article -
11
Safety, tolerability, pharmacokinetics and pharmacodynamics of a novel farnesoid X receptor (FXR) agonist-TQA3526 in healthy Chinese volunteers: a double-blind, randomized, placebo-controlled, dose-escalation, food effect phase I study
Published in Annals of medicine (Helsinki) (2023)“…TQA3526 is a novel farnesoid X receptor agonist developed to treat non-alcoholic steatohepatitis (NASH) or primary biliary cholangitis (PBC). This study aimed…”
Get full text
Journal Article -
12
Molecular Characterization and Expression Profile Analysis of Heat Shock Transcription Factors in Mungbean
Published in Frontiers in genetics (11-01-2019)“…Heat shock transcription factors (Hsfs) are essential elements in plant signal transduction pathways that mediate gene expression in response to various…”
Get full text
Journal Article -
13
Safety, pharmacokinetics and pharmacodynamics of a novel γ-aminobutyric acid (GABA) receptor potentiator, HSK3486, in Chinese patients with hepatic impairment
Published in Annals of medicine (Helsinki) (31-12-2022)“…The primary objective of this study was to investigate if hepatic impairment alters the safety, pharmacokinetics, and pharmacodynamics of HSK3486. This was a…”
Get full text
Journal Article -
14
Safety, Tolerability, and Pharmacokinetics of the Novel Hepatitis B Virus Capsid Assembly Modulator GST-HG141 in Healthy Chinese Subjects: a First-in-Human Single- and Multiple-Dose Escalation Trial
Published in Antimicrobial agents and chemotherapy (17-09-2021)“…Hepatitis B virus capsid assembly modulators (HBV CAMs) are promising, clinically validated therapeutic agents for the treatment of chronic hepatitis B (CHB)…”
Get full text
Journal Article -
15
Safety, Pharmacokinetics, and Pharmacodynamics of a Single Bolus of the γ-aminobutyric Acid (GABA) Receptor Potentiator HSK3486 in Healthy Chinese Elderly and Non-elderly
Published in Frontiers in pharmacology (27-08-2021)“…Background: The present clinical trial investigated the potential influences of dosage and age on the pharmacokinetic properties and safety profile of HSK3486,…”
Get full text
Journal Article -
16
A randomized phase-I pharmacokinetic trial comparing the potential biosimilar tocilizumab (QX003S) with the reference product (Actemra®) in Chinese healthy subjects
Published in Annals of medicine (Helsinki) (01-01-2021)“…QX003S is a biosimilar candidate for the reference tocilizumab, Actemra®. We investigated the tolerance, variability, and pharmacokinetics (PK) of QX003S…”
Get full text
Journal Article -
17
ZSP1601, a novel pan-phosphodiesterase inhibitor for the treatment of NAFLD, A randomized, placebo-controlled phase Ib/IIa trial
Published in Nature communications (12-10-2023)“…Non-alcoholic fatty liver disease is a growing health burden with limited treatment options worldwide. Herein we report a randomized, double-blind,…”
Get full text
Journal Article -
18
Tolerance, Variability and Pharmacokinetics of Albumin-Bound Paclitaxel in Chinese Breast Cancer Patients
Published in Frontiers in pharmacology (29-11-2018)“…The aim of this study was to explore the tolerance, variability, and pharmacokinetics (PK) of albumin-bound paclitaxel (QL, HR, ZDTQ) among Chinese breast…”
Get full text
Journal Article -
19
Bionic modeling and neurocomputing of synaptic transistor based on egg white as gate dielectric
Published in Journal of the Korean Physical Society (01-09-2024)“…Synaptic transistors are considered to hold great potential as electronic devices for constructing brain-inspired neuromorphic cognitive systems. Synaptic…”
Get full text
Journal Article -
20
HDV Seroprevalence in HBsAg-Positive Patients in China Occurs in Hotspots and Is Not Associated with HCV Mono-Infection
Published in Viruses (10-09-2021)“…HDV infection causes severe liver disease, the global health burden of which may be underestimated due to limited epidemiological data. HDV depends on HBV for…”
Get full text
Journal Article